Central nervous system stimulants and sport practice

British Journal of Sports Medicine

Volumn 40, Issue SUPPL. 1, 2006, Pages

  Avois, L ^a,b   Robinson, N ^b   Saudan, C ^b   Baume, N ^b   Mangin, P ^b   Saugy, M ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE; ANABOLIC AGENT; CAFFEINE; CENTRAL STIMULANT AGENT; COCAINE; EPHEDRINE; ILLICIT DRUG; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE; RECREATIONAL DRUG;

ABDOMINAL PAIN; AGGRESSION; ALLERGIC REACTION; AMNESIA; ANOSMIA; ANXIETY; CARDIOTOXICITY; CEREBROVASCULAR ACCIDENT; CONFUSION; CONTACT SPORT; CONVULSION; DELIRIUM; DEPRESSION; DISORIENTATION; DRUG ABSORPTION; DRUG EFFECT; DRUG EXCRETION; DRUG MECHANISM; DRUG METABOLISM; DRUG MISUSE; DRUG STRUCTURE; DYSPHAGIA; EPISTAXIS; EUPHORIA; FATIGUE; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HEADACHE; HEART ARREST; HEART ARRHYTHMIA; HEART INFARCTION; HEAT STROKE; HOARSENESS; HUMAN; HYPERTENSION; HYPERTHERMIA; INSOMNIA; INTESTINE ISCHEMIA; IRRITABILITY; MYDRIASIS; NAUSEA; NERVOUSNESS; PARANOIA; PRESCRIPTION; PSYCHOSIS; RESPIRATORY FAILURE; RESTLESSNESS; REVIEW; RHINORRHEA; SEIZURE; SIDE EFFECT; SPORTING EVENT; STROKE; SWEATING; TACHYCARDIA; THORAX PAIN; TRAINING; TREMOR; VASOCONSTRICTION;

AMPHETAMINE; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DOPAMINE UPTAKE INHIBITORS; DOPING IN SPORTS; EPHEDRINE; HUMANS; SPORTS;

EID: 33745849189     PISSN: 03063674     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjsm.2006.027557     Document Type: Review

References (28)

1. World Anti-Doping Agency website: www.wada-ama.org.
2. George AJ. CNS stimulants. In: Mottram DR, eds. Drugs in Sports, 2nd edn. London: E and F Spon, 1996.
3. Schwenk TL. Psychoactive drugs and athletic performance. Phys Sportsmed 1997;25:32-46.
4. Smith DA, Perry PJ. Part II, other performance-enhancing agents. The efficacy of ergogenic agents in athletic competition. Ann Pharmacother 1992;26:653-9.
5. Eichner ER. Ergolytic drugs in medicine and sports. Am J Med 1993;94:205-11.
6. Verroken M. Drug use and abuse in sport. Best Pract Res Clin Endocrinol Metab 2000;14:1-23.
7. George AJ. Central nervous system stimulants. Best Pract Res Clin Endocrinol Metab 2000;14:79-88.
8. Bohn AM, Khodaee M, Schwenk TL. Ephedrine and other stimulants as ergogenic aids. Curr Sports Med Rep 2003;2:220-5.
9. Seiden LS, Sabol KE, Ricaurte GA. Amphetamine: effects on catecholamine systems and behaviour. Ann Rev Pharmaco Toxicol 1993;32:639-77.
10. Silverstone T, Goodall E. How amphetamine works. In: Iverson SD, eds. Psychopharmacology: Recent Advances and Future Prospects. Oxford: Oxford University Press, 1985:315-25.
11. Laties VG, Weiss B. The amphetamine margin in sports. Fed Proc 1981;40:2689-92.
12. Smith GM, Beecher HG. Amphetamine sulphate and athletic performances. JAMA 1959;170:542-51.
13. Wyndham GH, Rogers GG, Bendade AJS, et al. Physiological effects of the amphetamines during exercise. South Afr Med J 1971,45:247-52.
14. Conlee RK. Amphetamine, caffeine and cocaine. In: Lamb DR, Williams MH, eds. Perspectives in Exercise Science and Sport Medicine. New York: Brown and Benchmark, 1991;4:285-328.
15. Fibiger HC, Philips AG, Brown EE. The neurobiology of cocaine-induced reinforcement. In: Wolstenholme GEW, eds. Cocaine: Scientific and Social Dimensions, Ciba Foundation Symposium no. 166. Chichester: John Wiley, 1992:64-80.
16. Kuhar MJ. Molecular pharmacology of cocaine: a dopamine hypothesis and its implications. In: Wolstenholme GEW, eds. Cocaine:Scientific and Social Dimensions, Ciba Foundation Symposium no. 166. Chichester: John Wiley, 1992:81-95.
17. Cantwell JD, Rose FD. Cocaine and cardiovascular events. Phys Sportmed 1981;14:77-82.
18. Kloner RA, Rezkalla SH. Cocaine and the heart. N Engl J Med 2003;348:487-8.
19. Welder AA, Melchert RB. Cardiotoxic effects of cocaine and anabolic-androgenic steroids in the athlete. J Pharmacol Toxicol Methods 1993;29:61-8.
20. Bell DG, Jacobs I, Ellerington K. Effects of caffeine and ephedrine ingestion on anaerobic exercise performance. Med Sci Sports Exer 2001;33:1399-403.
21. Bell DG, McLellan TM, Sabiston CM. Effects of ingesting caffeine and ephedrine on 10-km run performance. Med Sci Sports Exerc 2002;34:344-9.
22. Bell DG, Jacobs I, Zamecnik J. Effects of caffeine, ephedrine, and their combination on time exhaustion during high intensity exercise. Eur J Appl Physiol 1996;81:428-33.
23. Sidney KH, Lefcoe NM. The effects of ephedrine on the physiologic and psychological responses to submaximal and maximal exercise in man. Med Sci Sports 1977;9:95-9.
24. Bruno A, Nolte KB, Chapin J. Stroke associated with ephedrine use. Neurology 1993;43:1313-16.
25. Wooten MR, Khangure MS, Murphy MJ. Intracerebral hemorrhage and vasculitis related to ephedrine abuse. Ann Neural 1983;13:337-40.
26. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000;343:1833-8.
27. No authors listed. Adverse events with ephedra and other botanical dietary supplements. FDA Med Bull 1994;24:3.
28. No authors listed. FDA proposes constraints on ephedrine dietary supplements. Am J Health Syst Pharm 1997;54:1578.